The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Contraception Development Research Center Program (P50 Clinical Trial Optional)
The primary purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary approaches towards the development of new and/or improved contraceptive methods for both men and women through the formation of a Contraceptive Research Development Center. This FOA also allows the inclusion of translational studies to facilitate the pre-clinical to clinical transition and increase the likelihood of clinical success. Additionally, it allows for behavioral/social science, including market research to test user acceptability, research projects that are responding and well-coordinated to the contraceptive product being developed. The Center will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.
- Letter of Intent Due Date(s): 30 days prior to the application due date
- Application Due Date(s): November 29, 2021
RFA-HD-22-003 Expiration Date New Date November 30, 2021 per issuance of NOT-HD-20-044. (Original Expiration Date: March 31, 2021 )
Each Center should propose a budget that reflects the actual needs of the proposed projects and costs; the budget must not exceed $1.3 million per year in direct costs, excluding third party F&A. Future year amounts will depend on annual appropriations.
The scope of the proposed project should determine the project period. The maximum period of performance is 4 years.